How much funding has TEZCAT Laboratories LLC raised?

TEZCAT Laboratories LLC has raised $1.1M in total funding, most recently a Grant round.

Who are TEZCAT Laboratories LLC's investors?

TEZCAT Laboratories LLC's investors include National Cancer Institute.

When was TEZCAT Laboratories LLC founded?

TEZCAT Laboratories LLC was founded in 2020.

Where is TEZCAT Laboratories LLC headquartered?

TEZCAT Laboratories LLC is headquartered in New York, New York, United States.

What industry is TEZCAT Laboratories LLC in?

TEZCAT Laboratories LLC operates in Biotech, Drug Discovery, Healthcare.

How many employees does TEZCAT Laboratories LLC have?

TEZCAT Laboratories LLC has 1-10 employees.

TEZCAT Laboratories LLC

The Macropinocytosis Company

New York, United States · Founded 2020 · $1.1M raised

Biotech

Drug Discovery

Healthcare

Headquarters: New York, New York
Employees: 1–10
Founded: 2020
Business Model: B2B

Website: tezcat.co
Total Funding: $1.1M
Last Round: $1.1M GrantAug 2025
Rounds: 1

About

Tezcat Biosciences is an early-stage biopharmaceutical company that develops receptor-independent drug delivery technology for the most aggressive cancers. Born out of NYU Langone Health, its proprietary macropinocytosis platform delivers therapeutic payloads specifically to RAS-mutant tumor cells. Its lead asset TZT-102 targets relapsed/refractory multiple myeloma and is supported by NCI SBIR Phase II funding.

Summary

TEZCAT Laboratories LLC is a Biotech company based in New York, United States, founded in 2020. It has raised $1.1M in total across 1 round, most recently a $1.1M Grant round in Aug 2025. Investors include National Cancer Institute.